Evidence map›Paper›PMID 41822384›Full record

ArticleBioinformatics advances2026

GPTBioInsightor-leveraging large language models for transparent scRAN-seq cell type annotations.

Shenghui Huang, Berina Šabanović, Yuzhong Peng, Quan Zheng, Luca Alessandri, Christopher Heeschen

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shenghui HuangDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin (Torino) 10126, Italy.ORCID https://orcid.org/0000-0002-3714-1961
Berina ŠabanovićPancreatic Cancer Heterogeneity, Candiolo Cancer Institute - FPO - IRCCS, Candiolo (Torino) 10060, Italy.
Yuzhong PengFaculty of Health Sciences, University of Macau, Macau SAR 999078, China.
Quan ZhengCenter for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Luca AlessandriDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin (Torino) 10126, Italy.
Christopher HeeschenPancreatic Cancer Heterogeneity, Candiolo Cancer Institute - FPO - IRCCS, Candiolo (Torino) 10060, Italy.ORCID https://orcid.org/0000-0002-1158-8554

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Large language models (LLMs) are rapidly becoming indispensable across the life‑sciences spectrum, from literature mining through clinical decision support to experimental design. Yet, in single‑cell RNA‑sequencing (scRNA‑seq) analysis, most LLM‑enabled tools remain opaque: they output a single label per cluster without disclosing the chain‑of‑ thought that led to that decision. This opaqueness undermines reproducibility, complicates peer‑review, and ultimately slows the adoption of otherwise powerful methods. Results: We developed GPTBioInsightor, an LLM‑powered assistant that not only annotates cell types, cell states, and pathway activities but also narrates how it arrived at each conclusion, step-by-step. Across benchmark datasets-including peripheral blood mononuclear cells (PBMC3K) and pancreatic ductal adenocarcinoma-GPTBioInsightor achieved at least parity with expert manual curation while delivering transparent reasoning, confidence scores, and literature‑based evidence. By closing the "interpretability gap," GPTBioInsightor equips wet‑lab biologists, computational scientists, and reviewers with an audit‑ready trail, thereby accelerating discovery and fostering trust in AI‑assisted bioinformatics. Availability and implementation: GPTBioInsightor is freely available on GitHub under a BSD-3-Clause license (https://github.com/huang-sh/GPTBioInsightor).

Identifiers

PMID41822384
PMCPMC12975716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.